Jenny Chaplin

Jenny Chaplin joined Bellicum in 2018 and is Vice President, Strategic Operations. She has over 20 years of experience in research, development and program management, and alliance management encompassing both traditional drugs and cell therapies. Prior to joining Bellicum, Jenny was Director, Project Management at Pfizer, where she led cross-functional teams in early stage development of oncology therapies, focusing on their allogeneic CAR-T programs. Previously, she held roles of increasing responsibility in program management at Vical after transitioning from an early career in biocatalysis research. She received a B.Sc (Hons) from the University of the Witwatersrand in Johannesburg, South Africa.